Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Safety of Peficitinib in Healthy Chinese Subjects
NCT04143477Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Dec 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of peficitinib in rheumatoid arthritis (RA) (3 arms), sponsored by Astellas Pharma. Primary endpoints: Adverse Events, Laboratory Value Abnormalities and 12 more. Started Dec 2019; status: completed.
02
Drugs
peficitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04143477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04143477.